Propanc Biopharma - PPCB Company Short-Term Debt

propanc.com (PPCB) - corporate logo

Propanc Biopharma Inc (PPCB) is facing a severe liquidity shortage due to R&D expenditures. This chart from GURU.Markets tracks short-term loan debt, where the 0.00 mark serves as a key metric. Future patenting of proenzymes will ensure high margins, while success in cancer stem cell therapy and partnerships with pharma behemoths will act as the primary growth catalysts.

PPCB: Propanc Biopharma, Inc. Short-Term Debt 08/16/2025 - 10/28/2026

PPCB (Propanc Biopharma Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart Propanc Biopharma, Inc.|PPCB - Average Forecast Price
- market capitalization data:
Market Value Propanc Biopharma Inc.|PPCB - Total Company Value
- book capitalization data:
Net Assets per Single Share Propanc Biopharma|PPCB - Total Stockholders' Equity|Market Capitalization to Book Value Ratio propanc.com|PPCB - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Equity Ratio Propanc Biopharma Inc|PPCB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Propanc Biopharma, Inc.|PPCB - Aggregate Debt Obligations|Debt to Book Value Propanc Biopharma Inc.|PPCB - Amount of Long-Term Liabilities|Company Short-Term Debts Propanc Biopharma
Initial company analysis:PPCB (propanc.com)
Finished products of Propanc Biopharma Inc

To build a resilient portfolio, I evaluate the aggregate of promissory notes and credit lines with maturities of up to one year, which determines the issuer's current solvency. In the case of Propanc Biopharma Inc (PPCB), this metric reflects financial flexibility in maintaining insured logistics chains for enzyme delivery; therefore, analyzing the level of short-term liabilities reveals whether debt constraints are hindering operational continuity of supplies.

Competitors of Propanc Biopharma Inc (PPCB)

GMAB (Genmab) - Company Short-Term Debt|EXEL: Short-Term Debt|Nuvalent Corp (NUVL) - Company Short-Term Debt|KYMR (Kymera Corp) - Company Short-Term Debt|Company Short-Term Debt IDYA (IDEAYA Biosciences)|Short-Term Debt enliventherapeutics.com|ORIC: Company Short-Term Debts|Short-Term Indebtedness Relay Therapeutics Inc RLAY|NRIX: Company Current Liabilities|TYRA - Short-Term Debt|Company Current Liabilities Verastem, Inc. (VSTM)|monterosatx.com (GLUE) - Company Short-Term Loans and Borrowings|CGEM - Company Current Liabilities|Immuneering Corp (IMRX) - Amount of Current Liabilities|CCCC (C4 Tx) - Company Short-Term Debts|Company Short-Term Debts BDTX|Repare Therapeutics (RPTX) - Company Short-Term Debt|Company Short-Term Loans and Borrowings pmvpharma.com (PMVP)|KPTI (Karyopharm Therapeutics Inc.) - Company Short-Term Debts|Short-Term Indebtedness Bio Green Med Solution Inc. BGMS|AADI (Aadi Bio) - Company Short-Term Debts|Aileron Therapeutics (ALRN) - Short-Term Debt|BPMC - Company Current Liabilities|GlycoMimetics (GLYC) - Amount of Current Liabilities|Company Short-Term Debts SWTX (SpringWorks Therapeutics, Inc.)